These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23473065)

  • 1. Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.
    Delmonte L; Cantini M; Olivieri O; De Franceschi L
    Transfusion; 2013 Mar; 53(3):688-9. PubMed ID: 23473065
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction, intravenous immunoglobulin, and rituximab.
    Win N
    Transfusion; 2013 Nov; 53(11):2829-30. PubMed ID: 24580651
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N; Mialou V; Kebaïli K; Galambrun C; Bertrand Y; Pondarre C
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of delayed hemolytic transfusion reaction.
    Pirenne F
    Transfus Clin Biol; 2019 May; 26(2):99-101. PubMed ID: 30926306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR; Patel AR
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
    Boonyasampant M; Weitz IC; Kay B; Boonchalermvichian C; Liebman HA; Shulman IA
    Transfusion; 2015 Oct; 55(10):2398-403. PubMed ID: 25989361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
    Proudfit CL; Atta E; Doyle NM
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP; Ataga KI
    Am J Med Sci; 2010 Mar; 339(3):266-9. PubMed ID: 20051821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
    Reyes MA; Illoh OC
    Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE; Brand A; van Meurs A; Smiers FJ
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transfusion crises in sickle cell anemia.
    Milner PF; Squires JE
    Prog Clin Biol Res; 1987; 240():351-9. PubMed ID: 3615499
    [No Abstract]   [Full Text] [Related]  

  • 16. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute pancreatitis associated with massive hemolysis due to a delayed hemolytic transfusion reaction.
    Szymanski I; Seder R
    Transfusion; 2005 Oct; 45(10):1691-2. PubMed ID: 16181225
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed haemolytic transfusion reaction initially presenting as serum sickness like syndrome.
    Amrein K; Schmid P; Mansouri Taleghani B
    Eur J Intern Med; 2009 Sep; 20(5):e122-3. PubMed ID: 19712833
    [No Abstract]   [Full Text] [Related]  

  • 19. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S; Glasser CL
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.
    Seeyave D; Desai N; Miller S; Rao SP; Piecuch S
    J Natl Med Assoc; 2006 Oct; 98(10):1697-9. PubMed ID: 17052065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.